Sarcopenia is risk factor for prognosis of patients with biliopancreatic diseases
Hepatobiliary & Pancreatic Diseases International · 2025-12 · 24 (6) · 598-606
DOI: 10.1016/j.hbpd.2025.09.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatobiliary & Pancreatic Diseases International, 2025-12. Verfasst von Tomoya Emori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Wakayama Rosai Hospital, 93-1 Kinomoto, Wakayama 640-8505, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Biliary Tract Diseases, Pancreatic Diseases, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
The prevalence of sarcopenia tends to be high in patients with biliopancreatic disease. Sarcopenia is a risk factor of poor prognosis in patients with acute and chronic pancreatitis and biliary tract and pancreatic cancer. Several studies have suggested that sarcopenia may be a risk factor for perioperative complications and decreased recurrence-free or overall survival in patients with biliary tract and pancreatic cancer after surgery. Sarcopenia in biliary tract and pancreatic cancer may also increase chemotherapy-induced toxicities and worsen quality of life and survival in neoadjuvant or palliative chemotherapy. Moreover, sarcopenia is a risk factor for biliary stent occlusion in patients with malignant biliary obstruction, predictors of the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) for pain relief, EUS-guided drainage, and endoscopic necrosectomy for walled-off necrosis (WON). Diagnosis of sarcopenia prior to the treatment of biliopancreatic diseases and endoscopy may predict treatment efficacy, and appropriate nutritional and exercise therapy improve therapeutic outcomes of patients with biliopancreatic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Wakayama Rosai Hospital, 93-1 Kinomoto, Wakayama 640-8505, Japan.
- Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
- Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan. Electronic address: kitano@wakayama-med.ac.jp.
Zitieren
APA
Emori, T., Ashida, R., & Kitano, M. (2025). Sarcopenia is risk factor for prognosis of patients with biliopancreatic diseases. Hepatobiliary & Pancreatic Diseases International, 24(6), 598-606. https://doi.org/10.1016/j.hbpd.2025.09.005
Vancouver
Emori T, Ashida R, Kitano M. Sarcopenia is risk factor for prognosis of patients with biliopancreatic diseases. Hepatobiliary & Pancreatic Diseases International. 2025;24(6):598-606. doi:10.1016/j.hbpd.2025.09.005
BibTeX
@article{Emori2025,
author = {Emori, Tomoya and Ashida, Reiko and Kitano, Masayuki},
title = {Sarcopenia is risk factor for prognosis of patients with biliopancreatic diseases},
journal = {Hepatobiliary & Pancreatic Diseases International},
year = {2025},
volume = {24},
number = {6},
pages = {598--606},
doi = {10.1016/j.hbpd.2025.09.005}
}
EUVIMED